Scott Bluestein
Analyst · B. Riley FBR. Your line is now open
Thank you, Michael, and good afternoon, everyone, and thank you all for joining us today. Q1 was a standout quarter on multiple fronts for Hercules. As our leading position in the venture lending market continues to grow and strengthen, it affords us optionality that no other venture lender possesses. Our unique and proprietary origination platform combined with our internally managed structure is designed to deliver long-term, industry-leading shareholder returns. There are many approaches to bench our lending but none of them poses the proven ability to scale and deliver the level of sustained and consistent credit quality that Hercules has been able to demonstrate. The breadth, depth and diversity of our investment portfolio, which crossed $2 billion in Q1 is unmatched. In addition, the constant and diligent monitoring and communication with our 93 portfolio companies provides us with key leading economic visibility that helps us to navigate and mitigate risk on a forward-looking basis. In Q1, our deep and experienced team of best-in-class investment professionals delivered new debt and equity commitments of $414.8 million, our second highest in history. We funded $239.6 million during the quarter, while maintaining a modest level of available unfounded commitments of $154.2 million or only 7.2% of total assets. We carefully monitor and manage our unfunded commitments to ensure that we will always be in position to meet our borrowers’ need as and when they arise. Net debt portfolio growth of $160.5 million drove our debt investment portfolio to a record of $1.9 billion at cost. Our total investment portfolio grew by approximately 9% quarter-over-quarter and is up 40% from where it was in Q1 of 2018. This strong growth was achieved with the same underwriting discipline and credit focus that we have demonstrated on an consistent basis. As an internally managed BDC, we are simply not incentivized to grow our asset base at the expense of credit quality. Of the $414.8 million of Q1 commitments, $210 million was closed in the second half of March, clearly demonstrating the tremendous commitment, dedication and resilience of our investment team and platform. Since the close of Q1 and as of April 30, 2019, Hercules has closed new debt and equity commitments of $153.5 million and has pending commitments of $150.7 million in signed nonbinding term sheets. Year-to-date through April 30, 2019, our closed and pending new debt and equity commitments are at $719 million. As you can see, our deal pipeline remains healthy and robust, and our ability to close deals that meet or exceed our historical standards for quality, remained unabated. We remain optimistic by what we're seeing so far in Q2 2019 as we continue to be selective in our evaluation of and the potential conversion of our new deal pipeline currently at over $1.2 billion. While the top of our deal funnel has expanded, I will reiterate that we remain committed to the same underwriting discipline and credit focus that we have always maintained. We continue to pass on the majority of the deal opportunities that our investment team screens and evaluates, despite the continued strong competitive environment in our core markets. To support our optimistic growth outlook for 2019, we added two new investment professionals in Q1. We will continue to be both opportunistic and selective as we add to the investment team and other areas of the organization throughout the year with a focus on ensuring that we are positioning the Company for continued strength and manage growth. With our total investment portfolio now at $2.1 billion at cost and our debt investment portfolio at $1.9 billion at cost, combined with the size and quality of our pipeline and our current earnings spillover at $0.38 per share, we made the decision to increase our quarterly base distribution to $0.32 per share. In addition, we also announced a supplemental distribution of $0.01 per share. As a reminder, our Board maintains a variable distribution policy. So, we will continue to evaluate distribution as we move further into 2019. As we anticipate adding further to our scale, we’ve begun to modestly increase the use of leverage as previously stated, with Q1 coming in at 114.9% on a GAAP basis and regulatory leverage excluding our SBA debentures coming in at 99.9%. However, consistent with our previous guidance and conservative historical approach to leverage, we intend to be prudent as we manage leverage in 2019 to our desired target of 1.25 times and gradually step up above that level thereafter, if market conditions and deal quality remains favorable in 2020 and beyond. Credit quality remained consistent in Q1 with the weighted average internal credit rating of the death investment portfolio at 2.19 as compared to 2.18 in Q4 2018. Our rated 1 credits, as a percentage of our overall investment portfolio, went down slightly to 15.8% in Q1 from 18% in Q4, largely driven by chaos of several rated 1 credits that we were anticipating. Our rated 2 credits, as a percentage of our overall investment portfolio, increased to 55.7% in Q1 from 51.1% in Q4. And our rated 4 and rated 5 credits continue to make up less than 4% of our investment portfolio at fair value. Nonaccruals remained at historic lows with two debt investments on nonaccrual with a cumulative investment cost and fair value of approximately $2.4 million and $0.5 million, respectively, or 0.1% and 0.02% as a percentage of the Company's total investment portfolio and value respectively. We will continue to be vigilant and focused on credit, both from a macro and portfolio perspective as we move into the second half of 2019. We remain focused on delivering an investment portfolio that is intentionally diversified by stage, sector, geography and sponsor. After 15 years and over $8.9 billion of cumulative commitments, we believe that this is the best way to drive long-term, sustainable, shareholder and franchise value. During the first quarter, we closed new debt and equity commitments with 10 new and 8 existing portfolio companies. The scale that we have now archived and the size of our investment portfolio provides us with the unique ability to fund our borrowers through multiple value inflection points as they continue to grow and expand their own businesses. The profile of the 10 new companies that we made debt and equity commitments to during Q1, reflect our focus on delivering an investment portfolio that is highly diversified. We do not ascribe to the model of focusing singularly or exclusively on any one or group of sectors or sponsors. We continue to see and realize very strong loan demand and transaction deal flow volumes, driven in no small part by the robust U.S. venture capital-only investments activities which invested $24.6 billion and raised $15.5 billion during the first quarter of 2019. In addition, with many of the highly anticipated unicorn IPOs taking place, as VCs monetize their investments in these companies, it will provide another influx of future funding for investments in the next two to three years. Year-to-date 2019, we have had seven of our own portfolio companies, Stealth Bio Therapeutics, Avedro, X4, Lightspeed, Lyft, Pinterest and TransMedics complete their IPO debuts. Fastly has publically filed and we have three additional confidential filers. Assuming market conditions remain favorable, we are anticipating a very healthy pipeline of portfolio company IPOs for the remainder of 2019 and M&A exit activity in our portfolio to continue at a steady pace. M&A transactions continue to make up the majority of liquidity events for venture-backed companies. Historically, 90% of all exits are M&A related with Q1 ‘19 being at 95%. 173 companies were acquired for $30.7 billion in total versus 10 IPOs raising $3.3 billion in Q1. Given our strong start to 2019, we anticipate seeing continued NII growth in 2019, along with sustained portfolio growth and stable yields, assuming of course, market conditions remain favorable. Our performance in Q1 truly underscores the amazing depth and level of talent, discipline and diligence that our origination team has put forward and further, all of our employees’ contributions towards our continued growth and increasing shareholder returns. We take enormous pride in our human capital and advancing shareholder value. I would like to conclude by acknowledging and thanking each and every one of our 75 employees, 93 active borrowers, and key VC and sponsor partners for the tremendous support that we have received. Being able to partner with some of the most dynamic companies and with some of most creative and leading entrepreneurs while remaining focused on building shareholder value is what drives this team each and every day. Thank you very much, everyone. I will now turn the call over to Seth.